{"protocolSection": {"identificationModule": {"nctId": "NCT00626743", "orgStudyIdInfo": {"id": "SK3530_AMD_I_2007"}, "organization": {"fullName": "SK Chemicals Co., Ltd.", "class": "INDUSTRY"}, "briefTitle": "Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine", "officialTitle": "Clinical Trial to Investigate the Influence of SK3530 on the Blood Pressure of Patients With Hypertension Taking Amlodipine"}, "statusModule": {"statusVerifiedDate": "2014-03", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2008-05"}, "primaryCompletionDateStruct": {"date": "2009-05", "type": "ACTUAL"}, "completionDateStruct": {"date": "2011-07", "type": "ACTUAL"}, "studyFirstSubmitDate": "2008-02-21", "studyFirstSubmitQcDate": "2008-02-28", "studyFirstPostDateStruct": {"date": "2008-02-29", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2014-03-13", "resultsFirstSubmitQcDate": "2014-03-13", "resultsFirstPostDateStruct": {"date": "2014-04-21", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2014-03-13", "lastUpdatePostDateStruct": {"date": "2014-04-21", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "SK Chemicals Co., Ltd.", "class": "INDUSTRY"}}, "descriptionModule": {"briefSummary": "To assess the pharmacodynamic effects of co-administrated SK3530 (PDE5 inhibitor) and Amlodipine, phase I study in Hypertensive patient was designed."}, "conditionsModule": {"conditions": ["Hypertension"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE1"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "CROSSOVER", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 13, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "SK3530", "type": "EXPERIMENTAL", "description": "Active Drug", "interventionNames": ["Drug: SK3530 100mg, Placebo, Amlodipine"]}, {"label": "Placebo", "type": "PLACEBO_COMPARATOR", "description": "Tablet which has the same appearance and taste but doesn't contain active ingredient", "interventionNames": ["Drug: SK3530 100mg, Placebo, Amlodipine"]}], "interventions": [{"type": "DRUG", "name": "SK3530 100mg, Placebo, Amlodipine", "armGroupLabels": ["Placebo", "SK3530"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Maximal Change From Baseline in Standing SBP", "timeFrame": "within 8 hrs after SK3530 or placebo"}], "secondaryOutcomes": [{"measure": "Maximal Change From Baseline in Standing DBP", "timeFrame": "within 8 hrs after SK3530 or placebo"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Male subjects 19-65 years of age inclusive\n* Subjects with hypertension as defined 100 mmHg \u2264 SBP\\<140 mmHg and 65 mmHg \u2264 DBP \\< 90 mmHg after more than 5 minutes in the supine position\n* Written informed consent\n* Willing and able to comply with the requirements of the protocol\n\nExclusion Criteria:\n\n* Subjects with acute or chronic disease within 4 weeks of study initiation.\n* Subejcts with any gastrointestinal disorders known to alter drug absorption(except appendectomy, herniotomy, etc.)\n* Subjects with any clinically significant allergic disease or with a known allergy to the PDE5 inhibitors\n* Subjects with clinically significant abnormalities on laboratory tests\n* Subjects with orthostatic hypotension defined as a fall in systolic blood pressure of at least 20 mmHg or diastolic blood pressure of at least 10 mmHg when a person assumes a standing position\n* Subjects with abnormal QTc interval(\u2265440ms)\n* Subjects with color-blindness or weakness\n* Subejcts with alcohol, drug or caffeine abuse\n* Diet known to alter drug absorption, distribution, metabolism or elimination processes\n* Subjects who participated in other clinical studies within 2 months before an administration\n* Other subjects who are ineligible for the study at the discretion of the principle investigator or sub-investigators", "healthyVolunteers": false, "sex": "MALE", "minimumAge": "19 Years", "maximumAge": "65 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Jae Gook Shin, MD,PhD", "affiliation": "Inje University", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "INJE University Pusan Paik Hospital", "city": "Pusan", "country": "Korea, Republic of", "geoPoint": {"lat": 35.10278, "lon": 129.04028}}, {"facility": "Asan Medical Center", "city": "Seoul", "country": "Korea, Republic of", "geoPoint": {"lat": 37.566, "lon": 126.9784}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "SK3530", "description": "Active Drug\n\nSK3530 100mg, Placebo, Amlodipine"}, {"id": "FG001", "title": "Placebo", "description": "Tablet which has the same appearance and taste but doesn't contain active ingredient\n\nSK3530 100mg, Placebo, Amlodipine"}], "periods": [{"title": "Treatment Period 1", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "7"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "6"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}]}]}, {"title": "Wash-out Period of 6 Days", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "6"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "6"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}]}, {"title": "Treatment Period 2", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "6"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "6"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "INJE University Pusan Paik Hospital"}, {"id": "BG001", "title": "Asan Medical Center"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "8"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "13"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "48.63", "spread": "6.93"}, {"groupId": "BG001", "value": "54.00", "spread": "10.56"}, {"groupId": "BG002", "value": "50.69", "spread": "8.52"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "8"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "13"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Maximal Change From Baseline in Standing SBP", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "within 8 hrs after SK3530 or placebo", "groups": [{"id": "OG000", "title": "Amlodipine + SK3530"}, {"id": "OG001", "title": "Amlodipine + Placebo"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "12"}, {"groupId": "OG001", "value": "12"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-7.42", "spread": "5.60"}, {"groupId": "OG001", "value": "-4.42", "spread": "5.37"}]}]}]}, {"type": "SECONDARY", "title": "Maximal Change From Baseline in Standing DBP", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "within 8 hrs after SK3530 or placebo", "groups": [{"id": "OG000", "title": "Amlodipine + SK3530"}, {"id": "OG001", "title": "Amlodipine + Placebo"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "12"}, {"groupId": "OG001", "value": "12"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-7.17", "spread": "5.72"}, {"groupId": "OG001", "value": "-3.50", "spread": "3.37"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "about 6 weeks", "description": "Screening visit \\~ Post-study visit", "eventGroups": [{"id": "EG000", "title": "Amlodipine + SK3530", "seriousNumAffected": 0, "seriousNumAtRisk": 12, "otherNumAffected": 2, "otherNumAtRisk": 12}, {"id": "EG001", "title": "Amlodipine + Placebo", "seriousNumAffected": 0, "seriousNumAtRisk": 12, "otherNumAffected": 1, "otherNumAtRisk": 12}], "otherEvents": [{"term": "Dizziness", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 12}]}, {"term": "Flushing(facial flushing)", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 12}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}]}, {"term": "Vascular Headache(headache)", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 12}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 12}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release"}, "pointOfContact": {"title": "Jae Gook Shin, MD,PhD", "organization": "INJE University Pusan Paik Hospital", "email": "phshinjg@paik.ac.kr", "phone": "+82-51-890-8954"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-07-01"}, "conditionBrowseModule": {"meshes": [{"id": "D000006973", "term": "Hypertension"}], "ancestors": [{"id": "D000014652", "term": "Vascular Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M10024", "name": "Hypertension", "asFound": "Hypertension", "relevance": "HIGH"}, {"id": "M17400", "name": "Vascular Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000017311", "term": "Amlodipine"}], "ancestors": [{"id": "D000000959", "term": "Antihypertensive Agents"}, {"id": "D000002121", "term": "Calcium Channel Blockers"}, {"id": "D000049990", "term": "Membrane Transport Modulators"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000077264", "term": "Calcium-Regulating Hormones and Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000014665", "term": "Vasodilator Agents"}], "browseLeaves": [{"id": "M19600", "name": "Amlodipine", "asFound": "Healthy Volunteers", "relevance": "HIGH"}, {"id": "M4277", "name": "Antihypertensive Agents", "relevance": "LOW"}, {"id": "M5381", "name": "Calcium", "relevance": "LOW"}, {"id": "M5398", "name": "Calcium, Dietary", "relevance": "LOW"}, {"id": "M5384", "name": "Calcium Channel Blockers", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M17412", "name": "Vasodilator Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "AnAg", "name": "Antihypertensive Agents"}, {"abbrev": "ChanBlk", "name": "Channel Blockers"}, {"abbrev": "VaDiAg", "name": "Vasodilator Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "BDCA", "name": "Bone Density Conservation Agents"}]}}, "hasResults": true}